Laurion Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-30,530
| Closed | -$132K | – | 387 |
|
2023
Q3 | $132K | Buy |
+30,530
| New | +$132K | ﹤0.01% | 206 |
|
2020
Q4 | – | Sell |
-30,900
| Closed | -$298K | – | 734 |
|
2020
Q3 | $298K | Buy |
+30,900
| New | +$298K | ﹤0.01% | 488 |
|
2020
Q1 | – | Sell |
-14,800
| Closed | -$243K | – | 743 |
|
2019
Q4 | $243K | Sell |
14,800
-19,300
| -57% | -$317K | ﹤0.01% | 417 |
|
2019
Q3 | $453K | Buy |
34,100
+7,145
| +27% | +$94.9K | ﹤0.01% | 400 |
|
2019
Q2 | $380K | Buy |
+26,955
| New | +$380K | ﹤0.01% | 421 |
|
2018
Q4 | – | Sell |
-66,111
| Closed | -$1.52M | – | 963 |
|
2018
Q3 | $1.52M | Buy |
+66,111
| New | +$1.52M | 0.01% | 257 |
|
2018
Q2 | – | Sell |
-194,070
| Closed | -$3.27M | – | 1325 |
|
2018
Q1 | $3.27M | Buy |
+194,070
| New | +$3.27M | 0.03% | 256 |
|